18 Jun 2020 13:00
Horizon Discovery Group plc
Director/PDMR Shareholding - Grant of Share Options
Cambridge, UK, 18 June 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or "the Company"), a cell engineering company focused on commercialising the application of gene editing and gene modulation, announces that the following options were granted over the Company's ordinary shares of 1 pence each ("Ordinary Shares") on 18 June to Dr Siddartha Kadia.
Director | Number of Ordinary Shares over which options granted | Exercise price per share | Normal Vesting date - phased over three years |
Dr Siddhartha Kadia | 150,000 | £1.03 | 50,000 on 18 June 2021 50,000 on 18 June 2022 50,000 on 18 June 2023 |
The options granted are equivalent to 0.1% of the Company's existing issued share capital.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Dr Siddartha Kadia | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Director | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Horizon Discovery Group plc | |
b) | Legal Entity Identifier | 213800L812B9NI5M3G89 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Options over ordinary shares of 1.0 pence each GB00BK8FL363 | |
b) | Nature of the transaction | Grant of options to acquire ordinary shares under the Company's Long-Term Incentive Plan | |
c) | Currency | GBP | |
d) | Price(s) and volume(s) | Price | Volume |
103p | 150,000 | ||
| |||
e) | Aggregated information - Aggregated volume - Price - Aggregated total |
N/A | |
f) | Date of the transaction | 18 June 2020 | |
g) | Place of the transaction | London Stock Exchange, AIM | |
Ends
For further information from Horizon Discovery Group plc, please contact:
Horizon Discovery Group plc
Terry Pizzie, Chief Executive Officer
Jayesh Pankhania, Chief Financial Officer
Jon Davies, Head of Investor Relations
Tel: +44 (0) 1223 655 580
Numis Securities Limited (Broker and NOMAD)
Freddie Barnfield / Duncan Monteith
Tel: +44 (0) 207 260 1000
Consilium Strategic Communications (Financial Media and UK Investor Relations)
Mary-Jane Elliott / Matthew Neal / Melissa Gardiner
Tel: +44 (0) 20 3709 5700
Email: horizon@consilium-comms.com
Westwicke, an ICR Company (US Investor Relations)
Stephanie Carrington
Tel. +1 646-277-1282
Email: horizondiscovery@icrinc.com